We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VIRI market cap is 9.04M. The company's latest EPS is USD -0.2750 and P/E is -1.71.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.59M | -2.09M | -1.56M | -1.48M | -1.27M |
| Net Income | -2.58M | -2.05M | -1.52M | -1.44M | -1.24M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.18M | -10.01M | -15.64M | -12.32M | -5.45M |
| Net Income | -2.47M | -10.35M | -15.96M | -12.25M | -5.3M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.86M | 8.37M | 6.52M | 5.21M | 5.25M |
| Total Liabilities | 1.63M | 1.04M | 550k | 520k | 487k |
| Total Equity | 9.23M | 7.33M | 5.97M | 4.69M | 4.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 316k | 31.47M | 15.78M | 8.37M | 4.17M |
| Total Liabilities | 5.26M | 1.53M | 1.28M | 1.04M | 358k |
| Total Equity | -5.02M | 29.94M | 14.5M | 7.33M | 3.81M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.8M | -11.47M | -1.7M | -2.44M | -3.4M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.58M | 4.49M | N/A | N/A | 1.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.09M | -3.9M | -15.69M | -11.47M | -4.87M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.37M | 33.38M | -97k | 4.49M | 1.16M |
| Market Cap | 9.04M |
| Price to Earnings Ratio | -1.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.73 |
| Price to Book Ratio | 2.38 |
| Dividend Yield | - |
| Shares Outstanding | 19.26M |
| Average Volume (1 week) | 90.05k |
| Average Volume (1 Month) | 179.2k |
| 52 Week Change | -33.35% |
| 52 Week High | 2.42 |
| 52 Week Low | 0.279 |
| Spread (Intraday) | 0.06 (11.58%) |
| Company Name | Virios Therapeutics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.virios.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
